---
title: "Adisseo released its 2024 annual performance, with a net profit of 1.204 billion yuan, an increase of 2208.66%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229945403.md"
description: "Adisseo released its 2024 annual report, with operating revenue of 15.534 billion yuan, a year-on-year increase of 17.83%; net profit of 1.204 billion yuan, a year-on-year increase of 2208.66%. The net profit after deducting non-recurring gains and losses was 1.346 billion yuan, a year-on-year increase of 10258.60%. The basic earnings per share were 0.45 yuan, and it is proposed to distribute a cash dividend of 1.2 yuan for every 10 shares. The company's sales of liquid and solid methionine reached a record high, with a 24% increase in operating revenue from methionine products. Despite the rise in raw material prices, the gross profit margin still significantly improved. The specialty products business achieved stable growth"
datetime: "2025-02-27T15:56:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229945403.md)
  - [en](https://longbridge.com/en/news/229945403.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229945403.md)
---

# Adisseo released its 2024 annual performance, with a net profit of 1.204 billion yuan, an increase of 2208.66%

According to the Zhitong Finance APP, Adisseo (600299.SH) released its 2024 annual report, showing an operating income of 15.534 billion yuan, a year-on-year increase of 17.83%. The net profit attributable to shareholders of the listed company was 1.204 billion yuan, a year-on-year increase of 2208.66%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.346 billion yuan, a year-on-year increase of 10258.60%. The basic earnings per share were 0.45 yuan. In addition, it plans to distribute a cash dividend of 1.2 yuan (tax included) for every 10 shares to all shareholders.

According to the announcement, the company has maintained strong business growth for several consecutive quarters, leading to a significant increase in gross profit margin. Both liquid methionine and solid methionine sales reached historical highs, with the operating income of methionine product business achieving double-digit growth (+24%). Despite rising prices of some raw materials, the gross profit margin still achieved a significant increase compared to the previous year, thanks to the extremely high production stability of the methionine plant and rapid and timely supply chain management. Vitamin prices are expected to rebound by the end of 2024. Despite challenges in the dairy markets in China and the United States, the specialty products business still achieved stable growth (+4%)

### Related Stocks

- [600299.CN](https://longbridge.com/en/quote/600299.CN.md)

## Related News & Research

- [America’s consumer divide is growing](https://longbridge.com/en/news/287105871.md)
- [ZAWYA: Al Habtoor Tower: Dubai's boldest residential project yet](https://longbridge.com/en/news/287051508.md)
- [There is only one way Labour can win the North Sea oil and gas debate](https://longbridge.com/en/news/287246324.md)
- [Is RFK Jr.'s 'carnivore diet' healthy? Here's what you need to know.](https://longbridge.com/en/news/287079002.md)
- [I inherited a house. My CPA says I should sell within a year to avoid capital gains. Is he right?](https://longbridge.com/en/news/286876643.md)